Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00817752 · ClinicalTrials.gov registry record · Phase 1
Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation
A Phase 1 study, sponsored by National University of Natural Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT00817752 is a Phase 1 study that has completed, run by National University of Natural Medicine. The registered enrollment target is 25 participants.
The verdict
NCT00817752, a Phase 1 study, has completed, sponsored by National University of Natural Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
Ayurvedic medicine has been practiced in for more than 2,500 years. Ashwagandha is one of the most widely utilized herbs in the system. It is thought to affect the endocrine, immune, nervous, and cardiopulmonary systems. This study is designed as a preliminary investigation of the effects of Ashwagandha on stress, inflammation, and immune modulation. Participants will take the liquid extract in cow's milk twice a day for five days. The results of initial, one-day, and final blood draws will be compared to determine participant's beginning and ending levels of cortisol, inflammatory cytokines, and immune-cell activation (CD4 T-cells, CD8 T-cells, B cells and natural killer cells). Measurements will be completed using flow cytometry and ELISA assay. The purpose of this study is to determine which effects of Ashwagandha are most suitable for further investigation.
Interventions
- DIETARY_SUPPLEMENT Ashwagandha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00817752
The ClinicalTrials.gov registry entry for NCT00817752 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National University of Natural Medicine, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ashwagandha is the first listed.
NCT00817752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00817752 about?
NCT00817752 is a clinical study titled "Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation". Ayurvedic medicine has been practiced in for more than 2,500 years. Ashwagandha is one of the most widely utilized herbs in the system. It is thought to affect the endocrine, immune, nervous, and cardiopulmonary systems. This study is designed as a preliminary investigation of the effects of Ashwaga...
What is the current status of trial NCT00817752?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2007-05. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00817752?
The interventions under investigation include: Ashwagandha (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00817752?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.